
July 2024 to June 2025
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| PEMBROLIZUMAB | $684,837,779 | 80,712 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $618,283,563 | 29,291 |
| USTEKINUMAB | $520,141,537 | 73,997 |
| DUPILUMAB | $485,237,061 | 282,891 |
| AFLIBERCEPT | $476,264,467 | 485,078 |
| NIVOLUMAB | $420,278,751 | 58,522 |
| SEMAGLUTIDE | $341,479,742 | 2,863,083 |
| DENOSUMAB | $313,350,490 | 1,244,707 |
| UPADACITINIB | $287,107,401 | 197,442 |
| APIXABAN | $282,722,863 | 4,349,966 |
| OCRELIZUMAB | $238,559,468 | 14,562 |
| MOLNUPIRAVIR | $227,402,120 | 189,085 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $124,691,463 | 16,314,554 |
| ATORVASTATIN | $96,657,378 | 11,320,798 |
| PANTOPRAZOLE | $91,497,352 | 11,032,064 |
| ESOMEPRAZOLE | $74,423,270 | 7,974,968 |
| ESCITALOPRAM | $30,073,209 | 6,557,771 |
| PERINDOPRIL | $47,585,237 | 6,376,240 |
| SERTRALINE | $30,999,838 | 6,246,189 |
| METFORMIN | $50,554,500 | 6,148,020 |
| CEFALEXIN | $28,627,161 | 5,163,733 |
| AMOXICILLIN | $20,997,623 | 4,965,529 |
| AMLODIPINE | $36,677,369 | 4,708,184 |
| APIXABAN | $282,722,863 | 4,349,966 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $19,476,641,683 |
| Patients | $3,658,540,708 |